The Biomarker: Melanoma

Sanjiv S. Agarwala, MD
Video Categories: The Biomarker

PMO is pleased to offer the department “The Biomarker” to discuss the identification of biomarkers in patients with cancer and the prognostic/predictive impact and clinical decision-making implications of that marker. This month, we focus on KIT mutations in melanoma patients. Dr Sanjiv Agarwala provides his insights on this provocative topic.
January 30, 2014

Selecting the Appropriate Test for Individual Patients and Tumors

In this next segment, Dr Agarwala discusses when and how molecular tests should be utilized.

January 30, 2014

Personalized Medicine and Drug Development/Approval

Listen as Dr Agarwala presents how developments in personalized medicine will impact and change the way drugs are developed and approved.